The FDA has provided a date of April 18, 2025, to review the application for Dupixent to treat patients with chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback